Wearable Injectors and Connected Devices Conference 2019
9th-10th of October 2019, Copthorne Tara Hotel, Scarsdale Place, Kensington, London, UK
The global wearable devices market size is expected to reach a value of $12.1 billion USD by 2021 with time dependent delivery, large volume administration with minimal injection pain and the use of connectivity to enhance user-value being key factors driving the market.
With this in mind, the conference will explore new technologies and advances of on-body devices for the administration of viscous and large molecule drug delivery, and evaluate the impact of IoT, connectivity and enhancement of user-interface, which make up core components within the wearable devices field.
BENEFITS OF ATTENDING:
• LISTEN to case studies from leading pharmaceutical companies revolutionising the medical device industry
• HEAR how on-body injectors are facilitating the administration of time-dependent, large volume and viscous drug delivery
• ASSESS how connectivity is being used to improve patient adherence, health-monitoring and enhancing the user-interface
• EXPLORE the compatibility, pain and patient handling considerations projecting wearable devices as the future of drug delivery
PLUS TWO INTERACTIVE PRE-CONFERENCE WORKSHOPS
Tuesday 8th October 2019
Cross company collaboration to develop digital therapeutic solutions using connected devices
Workshop Leader: Digby Harris, Global Category Manager – Digital Therapeutics & Devices, AstraZeneca
Wearable injectors: Envisioning their evolution to address current and future unmet needs
Workshop Leader: James Blakemore, Senior Consultant, Cambridge Consultants
Workshop Leader: Sergio Marlorni, Senior Consultant, Cambridge Consultants
WHO SHOULD ATTEND?
Executives, Directors, VPs, Heads, Principals, Managers of: Drug-delivery developers, Autoinjectors, Device Engineering, Human Factor, Scientist, Product, Injectables, Packaging, Regulatory Affairs, Connectivity, Medical Device Data, Novel Product Technology, Smart device developers, Training device developers, Device-safety solution providers, Drug developers or anyone who works with Wearable Devices/ On-Body Injectors within pharmaceutical, biotech and solution providers.
For more details visit: www.wearable-injectors.co.uk/farmavitawl